The antimalarial drug candidate for coronavirus has long been introduced as a 'game-changer' in treating COVID-19 patients. However, in recent studies, contrasting results have been seen in patients. Some claim to have improved their condition with the help of the drug, while others blame the cure for the adverse reactions it brings. A new study from New York suggests that the drug may yield better results when used in combination with the dietary supplement, zinc. Researchers from the NYU Grossman School of Medicine placed a medical preprint on their site on Monday. Their paper is yet to be peer-reviewed. In...